A Study of ADX-102 in Subjects With Allergic Conjunctivitis

NCT03012165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Conjunctivitis, Allergic

Interventions

DRUG: ADX-102 Ophthalmic Drops (0.5%)
DRUG: ADX-102 Ophthalmic Drops (0.1%)
DRUG: Vehicle of ADX-102 Ophthalmic Drops

Sponsor

Aldeyra Therapeutics, Inc.

Collaborators

[object Object]